Please wait

Exhibit 107
Calculation of Filing Fee Tables
Form S-8
(Form Type)

Infinity Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)

Table 1—Newly Registered Securities

Security
Type
 
Security Class
Title
 
Fee
Calculation
Rule
 
Amount
Registered
(1)
 
Proposed
Maximum
Offering
Price Per
Unit
   
Maximum
Aggregate
Offering Price
   
Fee Rate
 
Amount of
Registration
Fee
 
Equity
 
Common Stock, $0.001 par value per share
 
Other
 
30,000 shares (2)
   
$0.1921 (3)
     
$5,763.00 (3)
   
$110.20
per $1,000,000
   
$0.64
 
Total Offering Amounts
           
 $5,763.00
         
$0.64
 
Total Fee Offsets
                       
 
Net Fee Due
                       
$0.64
 

(1)
In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.

(2)
Consists of 30,000 shares issuable under a nonstatutory stock option award pursuant to a nonstatutory stock option agreement entered into by the Registrant with Kenneth Duong, the Registrant’s Associate Director, Supply Operations, which was granted on April 6, 2022 in accordance with Nasdaq Listing Rule 5635(c)(4).

(3)
Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act. The price per share and aggregate offering price are calculated on the basis of the average of the high and low sale prices of the registrant’s common stock on the Nasdaq Global Market on March 24, 2023, in accordance with Rule 457(c) under the Securities Act.